drugset / Trial / NCT04976543

Safety of Anticoagulant Therapy After Endoscopic Treatment

NCT04976543

RandomizedParallel-groupSingle-blindTreatment

Summary

The investigators aimed to verify the efficacy and safety of nadroparin calcium warfarin sequential (NWS) anticoagulation therapy after endoscopic therapy in PVT patients with cirrhosis and AVB.

Timeline

Start
2020-02-01
Primary completion
2021-12-31
Completion
2022-06-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Nadroparin Calcium Other / unclassified Subcutaneous
Subject Warfarin Small molecule Oral